Sinsin Pharmaceutical Co. Ltd Market Cap ($40.81 Million)
Market Cap & Net Worth: Sinsin Pharmaceutical Co. Ltd (002800)
Sinsin Pharmaceutical Co. Ltd market cap. Sinsin Pharmaceutical Co. Ltd (KQ:002800) has a market capitalization of $40.81 Million (₩60.23 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22460 globally and #1452 in its home market, demonstrating a -2.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinsin Pharmaceutical Co. Ltd's stock price ₩3970.00 by its total outstanding shares 15170500 (15.17 Million). Also see 002800 operating cash flow for how efficiently the company converts equity into cash flow.
Sinsin Pharmaceutical Co. Ltd Market Cap History (2017–2026)
Sinsin Pharmaceutical Co. Ltd market cap history from 2017 to 2026. Data shows change from $74.85 Million to $40.81 Million (-6.67% CAGR). Check 002800 stock price and chart for real-time trading data and today's change.
Index Memberships
Sinsin Pharmaceutical Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$211.91 Billion | 0.02% | #703 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$211.91 Billion | 0.02% | #703 of 1384 |
Weight: Sinsin Pharmaceutical Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sinsin Pharmaceutical Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sinsin Pharmaceutical Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Sinsin Pharmaceutical Co. Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Sinsin Pharmaceutical Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Sinsin Pharmaceutical Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $74.85 Million | $61.73 Billion | $3.60 Billion | 0.00x | 0.02x |
| 2018 | $73.51 Million | $63.72 Billion | $2.90 Billion | 0.00x | 0.03x |
| 2019 | $68.68 Million | $67.85 Billion | $2.14 Billion | 0.00x | 0.03x |
| 2020 | $92.34 Million | $67.13 Billion | $362.66 Million | 0.00x | 0.25x |
| 2021 | $65.17 Million | $74.01 Billion | -$1.48 Billion | 0.00x | N/A |
| 2022 | $56.89 Million | $91.93 Billion | $4.41 Billion | 0.00x | 0.01x |
| 2023 | $64.15 Million | $102.59 Billion | $4.68 Billion | 0.00x | 0.01x |
| 2024 | $55.82 Million | $106.39 Billion | $4.89 Billion | 0.00x | 0.01x |
Competitor Companies of 002800 by Market Capitalization
Companies near Sinsin Pharmaceutical Co. Ltd in the global market cap rankings as of November 3, 2026. Also see 002800 total asset value for a full breakdown of the balance sheet.
Key companies related to Sinsin Pharmaceutical Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Sinsin Pharmaceutical Co. Ltd (2017–2026)
Market capitalization of Sinsin Pharmaceutical Co. Ltd from 2017 to today. Between 2017 and today, Sinsin Pharmaceutical Co. Ltd's market cap moved from $74.85 Million to $ 40.81 Million, with a yearly change of -6.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩40.81 Million | -32.25% |
| 2025 | ₩60.25 Million | +7.92% |
| 2024 | ₩55.82 Million | -12.98% |
| 2023 | ₩64.15 Million | +12.76% |
| 2022 | ₩56.89 Million | -12.70% |
| 2021 | ₩65.17 Million | -29.43% |
| 2020 | ₩92.34 Million | +34.45% |
| 2019 | ₩68.68 Million | -6.56% |
| 2018 | ₩73.51 Million | -1.80% |
| 2017 | ₩74.85 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Sinsin Pharmaceutical Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.81 Million USD |
| MoneyControl | $40.81 Million USD |
| MarketWatch | $40.81 Million USD |
| marketcap.company | $40.81 Million USD |
| Reuters | $40.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sinsin Pharmaceutical Co. Ltd
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery … Read more